Randomised study of anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women
- 1 September 2000
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 36, 84-85
- https://doi.org/10.1016/s0959-8049(00)00239-2
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinomaCancer, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Cardiac and Thromboembolic Morbidity Among Postmenopausal Women With Early Stage Breast Cancer in a Randomized Trial of Adjuvant TamoxifenJNCI Journal of the National Cancer Institute, 1993
- Endocrine Therapy of Advanced Breast CancerActa Oncologica, 1988